How long the pneumonia vaccine lasts, and when a second type is added

How Long Does the Pneumonia Vaccine Last—and When a Second Type Is Added

Pneumonia remains a leading cause of serious illness in older adults and people with certain health conditions. Vaccination is our best tool to prevent severe infection, hospitalization and even death. Understanding how long the pneumonia vaccine lasts and when a second type is recommended can help you and your doctor make the right plan.

---

1. Why Pneumonia Vaccination Matters

• Pneumonia is an infection of the lungs often caused by the bacterium Streptococcus pneumoniae.
• Symptoms range from cough, fever and chest pain to difficulty breathing.
• Vaccines can prevent many of the most dangerous strains and reduce complications, hospital stays and healthcare costs.
• Adults over 65 and people with weakened immune systems or chronic illnesses are at highest risk.

---

2. The Two Main Pneumococcal Vaccines

There are two categories of pneumococcal vaccines licensed in the U.S.:

1. Pneumococcal Conjugate Vaccines (PCV)

   • Examples: PCV13 (Prevnar 13), PCV15 (Vaxneuvance), PCV20 (Prevnar 20)
   • Designed to train the immune system to recognize 13–20 common “serotypes” of the bacteria.

2. Pneumococcal Polysaccharide Vaccine (PPSV23)

   • Example: PPSV23 (Pneumovax 23)
   • Covers 23 serotypes, including some not in PCV vaccines.

Each type triggers a slightly different immune response. In some cases, both are used in sequence to maximize protection.

---

3. How Long Does the Pneumonia Vaccine Last?

PCV13, PCV15 and PCV20

• Duration of Protection:
  – Studies of PCV13 show robust antibody levels for at least 5 years, with ongoing protection up to 10 years in many adults.
  – PCV15 and PCV20 are newer but expected to provide a similar duration of protection (5–10 years).
• Why It Lasts This Long:
  – Conjugate technology creates a “memory” in the immune system.
  – Booster responses remain strong if re-exposure occurs.

PPSV23

• Duration of Protection:
  – Antibody levels peak about 4–6 weeks after vaccination, then gradually decline.
  – Protection against invasive pneumococcal disease is strong for about 5 years.
  – After 5 years, immunity can wane, especially in adults over 65 or those with chronic illness.
• Boosters:
  – Routine repeat doses (booster shots) are generally not recommended for most healthy adults but may be advised for certain high-risk groups (e.g., people with asplenia or kidney disease) after 5 years.

---

4. When a Second Type Is Added

Combining PCV and PPSV23 in a schedule maximizes coverage across multiple serotypes. Current U.S. CDC guidelines recommend:

Adults 65 and Older

• Option A (PCV15 then PPSV23)
  1. One dose of PCV15
  2. One dose of PPSV23 at least 1 year later
• Option B (PCV20 alone)
  • Single dose of PCV20, no PPSV23 needed

Adults 19–64 with Certain Conditions

• Immunocompromising conditions, cochlear implants, cerebrospinal fluid leaks, or microbiological risk factors:
  1. PCV13 (or PCV15/PCV20) first
  2. PPSV23 at least 8 weeks later (PCV15) or 1 year later (PCV13)

Why Two Types?

• Broader coverage: PCV covers 13–20 serotypes with strong, longer-lasting memory response. PPSV23 adds protection against 23 total serotypes, including those not in PCV.
• Optimal timing: Spacing out vaccines (8 weeks to 1 year apart) ensures the immune system mounts a strong, non-overlapping response.

---

5. Do You Need a Booster?

• Generally, no routine booster for healthy adults after the initial series.
• High-risk groups (e.g., immunocompromised, asplenia, chronic kidney disease) may benefit from a single PPSV23 booster 5 years after the first dose.
• Check with your doctor if you have ongoing health issues or special risk factors.

---

6. Common Side Effects

Most side effects are mild and temporary:

• Pain, redness or swelling at the injection site
• Low-grade fever or chills
• Fatigue or muscle aches

Serious allergic reactions are very rare. Vaccination benefits far outweigh the risks for most people at risk for pneumonia.

---

7. Staying Vigilant: Know Your Symptoms

Even vaccinated individuals can get pneumonia—though it’s usually milder. If you experience:

• High or persistent fever
• Difficulty breathing or rapid breathing
• Chest pain, especially when breathing or coughing
• Confusion or decreased alertness

…seek prompt medical attention. You might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide if you need to see a healthcare provider.

Link: free, online symptom check, using the doctor approved Ubie Symptom Checker

---

8. Key Takeaways

• Protection lasts about 5–10 years for PCV vaccines and about 5 years for PPSV23.
• Most adults 65+ need just one pneumococcal series: either PCV20 alone or PCV15 followed by PPSV23.
• High-risk adults 19–64 often require both PCV and PPSV23 spaced 8 weeks to 1 year apart.
• Boosters are reserved for certain high-risk groups, typically 5 years after initial PPSV23.
• Side effects are usually mild; serious reactions are rare.

---

9. Talk to Your Doctor

Decisions about pneumonia vaccination schedules should be personalized. Discuss your age, health conditions and vaccine history with your doctor. If you develop symptoms that could be life-threatening or serious, seek medical care right away.

Staying up to date helps protect you and those around you from severe pneumonia.